Interaction Between NGF and Acute Exercise-induced Ischemia
Hyperalgesia, Pain Response, Healthy Subjects
About this trial
This is an interventional basic science trial for Hyperalgesia focused on measuring NGF-induced pain, Ischemia-induced pain, Hyperalgesia, NGF pain model
Eligibility Criteria
Inclusion Criteria:
- Healthy and pain free volunteers
Exclusion Criteria:
- Pregnancy
- Drug addiction defined as the use of cannabis, opioids or other drugs
- Previous neurologic, mental illnesses, or psychiatric diseases.
- Past history of chronic pain in the musculoskeletal system (muscle, joint, cartilage, connective tissue)
- Participation in other pain trials throughout the study period
- Lack of ability to cooperate
- Taking any analgesic 24 hours before the injections
- Performing any strenuous leg exercise through out the study period causing sore muscles
Sites / Locations
- Aalborg University
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
NGF condition + Control condition
Control condition + NGF condition
All participants will receive five injections with NGF (1ug/0.5ml) into the tibialis anterior muscle in their non-dominant leg After 4 weeks: All participants will receive five injections with isotonic saline (9%/0.5ml) into the tibialis anterior muscle in their non-dominant leg
All participants will receive five injections with isotonic saline (9%/0.5ml) into the tibialis anterior muscle in their non-dominant leg After 4 weeks: All participants will receive five injections with NGF (1ug/0.5ml) into the tibialis anterior muscle in their non-dominant leg